Could early CPAP help sleep apnea patients while they wait for a diagnosis?
NCT ID NCT07693101
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study looks at whether starting CPAP therapy early for people with suspected obstructive sleep apnea (OSA) can improve their daytime sleepiness and quality of life while they wait for a formal sleep study. Participants are adults with strong signs of OSA, such as loud snoring and severe sleepiness. They will use an Auto-CPAP machine set to a practical pressure range. The study measures changes in sleepiness and daily functioning, and checks how well the early CPAP settings match the final ones from the sleep study.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Auto-CPAP machine
- What this could lead to
- If successful, this approach could reduce delays in treating sleep apnea in areas with limited access to sleep labs, improving patients' daily functioning and sleep quality.
- What could go wrong
- This is an observational study with a small sample size, so results may not apply broadly. Early CPAP may not match the optimal pressure from a formal sleep study, and benefits may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population consists of adult patients (aged 18 years and older) attending the Chest Department at Assiut University Hospital who present with symptoms suggestive of Obstructive Sleep Apnea (OSA), such as excessive daytime sleepiness, habitual snoring, or witnessed apnea. Eligible patients must have a high clinical probability of OSA, defined as having a STOP-BANG score of 5 or greater, or a STOP-BANG score of 3 to 4 combined with an Epworth Sleepiness Scale (ESS) score of 10 or greater. Furthermore, the population is specifically composed of individuals who are currently awaiting diagnostic polysomnography (PSG) due to delayed access to sleep laboratory services in a resource-limited setting.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥18 years. * Patients presenting with symptoms suggestive of OSA, including one or more of the following: excessive daytime sleepiness, habitual snoring, witnessed apnea during sleep, non-restorative sleep, or morning headache. * High clinical probability of OSA defined by: STOP-BANG score ≥5 or STOP-BANG score 3-4 with ESS ≥10. * Patients awaiting diagnostic PSG due to delayed access to sleep laboratory services. * Patients with OSAS and COPD overlap. * Obesity hypoventilation syndrome requiring automated CPAP. * Ability and willingness to use CPAP and provide informed consent. Exclusion Criteria: * Age \<18 years. * Pregnancy. * Previous PSG-confirmed OSA with prescribed CPAP settings. * Predominant central sleep apnea. * Cheyne-Stokes respiration. * Neuromuscular disorders affecting respiration. * Severe psychiatric illness impairing adherence. * Inability to provide informed consent. * Severe unstable cardiopulmonary disease requiring urgent respiratory support, including: acute heart failure, acute coronary syndrome, acute respiratory failure, or severe COPD with chronic hypercapnic respiratory failure requiring NIV rather than CPAP. * Obesity hypoventilation syndrome requiring bilevel PAP (BiPAP) instead of CPAP.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obesity hypoventilation syndrome are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Real-world evaluation of the clinical performance and safety of apneal dx for the screening and aid in the diagnosis of obstructive sleep apnea-hypopnea syndrome in adults: a post-market clinical follow-up study
- A smart neck brace may replace CPAP for sleep apnea
- Can new home monitors keep tabs on breathing support without a clinic visit?
- A blood test for liver trouble may flag hidden risk in sleep apnea patients
- Blood oxygen dips may reveal who stays on CPAP
- Can a simple questionnaire improve sleep apnea treatment?